CoChat

Probiotics in irritable bowel syndrome: underachievers or underpowered? authors’ reply

Open access
Simrén, M., ÖHman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., Strid, H. · 2010 · Alimentary Pharmacology & Therapeutics
Cited by 23

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Sirs, We wish to thank Dr Ford for his interest1 in our recent article published in APT.2 In essence, we agree with the comments made by Dr Ford, and a very likely explanation for the lack of statistical significance between the active treatment group and the control group is that the study was under-powered. However, we have to stress that our assumption of the placebo response rate (15%), using our responder definition, is closer to the observed placebo response in our study (27%), than the pooled placebo response rate from the recent systematic review (43%),3 mentioned by Dr Ford in his letter. Therefore, the incorrect assumption of the placebo response rate does not seem to be a major explanation behind the lack of a statistical difference between the groups. To conclude, we agree that larger studies are needed to assess the effect of probiotics in IBS, to obtain a response to the question posed in the letter by Dr Ford: ‘Probiotics in IBS: underachievers or underpowered?’ We tend to believe that underpowered studies contribute to some of the negative results in the literature, but differences between probiotic products are also of potential importance. Declaration of personal interests: Magnus Simrén has served as a speaker or advisor for AstraZeneca, Novartis, Albireo, Danone, Movetis Addex and Succampo, and has received research funding from AstraZeneca and Danone. Johan Olsson is an employee of KPL Good Food Practice. Ulla Svensson and Kajsa Ohlson are employees of Arla Foods Innovation. Declaration of funding interests: The original study was supported by an unrestricted grant from Arla Foods Innovation, Stockholm, Sweden to the department of Internal Medicine, Sahlgrenska University Hospital, Sweden. This study was supported by the Swedish Medical Research Council (grant 13409), and by the Faculty of Medicine, University of Göteborg.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2010.04239.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 23

Metadata

Authors
Simrén, M., ÖHman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., & Strid, H.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2010-03-17
Volume
31
Issue
8
Pages
923-924
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1803376482
Cited by
23
References
2
FWCI
3.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics in irritable bowel syndrome: underachievers or underpowered? authors’ reply. https://app.cochat.ai/papers/10.1111/j.1365-2036.2010.04239.x
The paper
Simrén, M., ÖHman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., & Strid, H. (2010). Probiotics in irritable bowel syndrome: underachievers or underpowered? authors’ reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2010.04239.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.